ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HAE Haemonetics Corp

88.73
2.14 (2.47%)
20 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Haemonetics Corp NYSE:HAE NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  2.14 2.47% 88.73 89.05 86.735 86.79 326,961 01:00:00

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

08/07/2024 9:05pm

PR Newswire (US)


Haemonetics (NYSE:HAE)
Historical Stock Chart


From Jun 2024 to Jul 2024

Click Here for more Haemonetics Charts.

BOSTON, July 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, August 8, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on August 8, 2024.

The call can be accessed via teleconference at: Q1 2025 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/qeo7r49a 

A replay of the conference call and webcast will be available for one year beginning on August 8, 2024 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:                                                     


Olga Guyette, Vice President-Investor Relations & Treasury 

David Trenk, Manager-Investor Relations

(781) 356-9763                                                                

(203) 733-4987

olga.guyette@haemonetics.com

david.trenk@haemonetics.com                     



Media Contact:                                  


Josh Gitelson, Sr. Director-Global Communications       


(781) 356-9776


josh.gitelson@haemonetics.com 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2025-results-august-8-2024-302191202.html

SOURCE Haemonetics Corporation

Copyright 2024 PR Newswire

1 Year Haemonetics Chart

1 Year Haemonetics Chart

1 Month Haemonetics Chart

1 Month Haemonetics Chart

Your Recent History

Delayed Upgrade Clock